What is the current stock price of MDxHealth S.A. (MXDHF)?

As of the latest market data, MDxHealth S.A. (MXDHF) is trading at $0.25. The stock has seen a loss of -9.09% today.

Does MDxHealth S.A. (MXDHF) pay a dividend?

Based on current data, MDxHealth S.A. does not have a confirmed active dividend policy.

What is the market cap of MDxHealth S.A.?

The current market capitalization of MDxHealth S.A. (MXDHF) is approximately unavailable.

MXDHF

MDxHealth S.A.·Healthcare

0.25

9.091%(−0.03)

Close Price

Last Updated: — ET

52W L: $0.0052W H: $0.65

MXDHF NEWS

marketbeat.com

May 13

MDxHealth Q1 Earnings Call Highlights

MDxHealth NASDAQ: MDXH reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company's focus on prostate cancer diagnostics.

seekingalpha.com

May 13

MDxHealth SA (MDXH) Q1 2026 Earnings Call Transcript

defenseworld.net

Mar 21

Head to Head Analysis: C.P. Pokphand (OTCMKTS:CPKPY) and MDxHealth (OTCMKTS:MXDHF)

C.P. Pokphand (OTCMKTS:CPKPY - Get Free Report) and MDxHealth (OTCMKTS:MXDHF - Get Free Report) are both consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, dividends and profitability. Profitability This table compares C.P. Pokphand and MDxHealth's

Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

252

IPO Date

2014-04-17

Beta

0.73

Websitemdxhealth.com↗